Prostaglandin D2 receptor antagonism: a novel therapeutic option for eosinophilic asthma?

2016-09-01

The Lancet Respiratory Medicine , Volume 4 - Issue 9 p. 676- 677

Additional Metadata
Persistent URL	doi.org/10.1016/S2213-2600(16)30201-6, hdl.handle.net/1765/97299
Journal	The Lancet Respiratory Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Brusselle, G., Provoost, S., & Maes, T. (2016). Prostaglandin D2 receptor antagonism: a novel therapeutic option for eosinophilic asthma?. The Lancet Respiratory Medicine (Vol. 4, pp. 676–677). doi:10.1016/S2213-2600(16)30201-6

Publication